Search - tctmd.com

Displaying 1 - 20 of 94

Sort: Relevancy | Date

News Daily News

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

L.A. McKeown

June 12, 2025

News Conference News CX Symposium 2025

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

L.A. McKeown

April 30, 2025

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Conference News SCAI 2024

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

L.A. McKeown

May 10, 2024

News Daily News

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

L.A. McKeown

April 24, 2024

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

News Conference News ISET 2024

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Caitlin E. Cox

January 24, 2024

News Daily News

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

L.A. McKeown

January 19, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Daily News

AHA Scientific Statement Urges Incorporation of Mental Health Care in PAD

L.A. McKeown

October 06, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Conference News LINC 2023

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

L.A. McKeown

June 09, 2023

News Conference News SCAI 2023

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

L.A. McKeown

May 24, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Conference News ISET 2023

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

Caitlin E. Cox

January 20, 2023

Advertisement

GLP-1s Reduce Limb and Cardiac Events in Peripheral Artery Disease

Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

September 2024 Dispatch for the CV Team

No Sex-Specific Differences in PAD Therapy Outcomes: REVIVE Analysis

BASIL-3: More Questions Than Answers About Drug-Coated Devices in CLTI

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

January 2024 Dispatch for the CV Team

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

AHA Scientific Statement Urges Incorporation of Mental Health Care in PAD

October 2023 News Roundup

Early Data on Temporary Spur in BTK PAD Show Efficacy, Limited Recoil

Real-World CLTI Patients, Outcomes Are a Departure From BEST-CLI

Only Half of Revascularized PAD Patients Receive GDMT

BioMimics 3D Stent Holds Up Well at 3 Years in Complex PAD Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content